Search clinical trials for: fulvestrant

Total 469 results

Institute of Cancer Research, United Kingdom

Unknown

Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United Kingdom
Sanofi

Terminated

Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

Breast Neoplasms

France, Italy, Spain
AstraZeneca

Completed

Faslodex Advanced Breast Cancer Local Chinese Study

Advanced Breast Cancer

China
AstraZeneca

Completed

Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France

Breast Cancer
AstraZeneca

Completed

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer (FRAME)

Breast Cancer

Argentina
AstraZeneca

Completed

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer (@FAME)

Breast Cancer

Germany, Norway, Austria
AstraZeneca

Completed

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Advanced Breast Cancer

Japan
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Ovarian Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

Leukemia

United States
AstraZeneca
Dendrix - Scientific Information Architecture

Completed

Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

Breast Cancer

Brazil
AstraZeneca

Completed

Faslodex Registry: Fulvestrant in Current Clinical Practice

Metastatic Breast Cancer

Belgium
The Center for Rheumatic Disease, Allergy, & Immunology
AstraZeneca

Completed

Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies

Systemic Lupus Erythematosus

United States
AstraZeneca

Completed

A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer

Breast Cancer

Spain
AstraZeneca

Completed

Second Line Breast Cancer Trial

Advanced Breast Cancer
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer

Breast Cancer

France
AstraZeneca

Completed

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Breast Cancer

United States, Brazil, United Kingdom, Germany, Austria, India
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Breast Cancer

United States
AstraZeneca

Completed

SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer

Breast Neoplasms

Belgium, Switzerland
Lederle Laboratories

Completed

Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma

HIV Infections | Sarcoma, Kaposi

United States

3

Subscribe